Cited by 61Renal Transplantation Outcomes and TreatmentsOrgan Donation and TransplantationTransplantation: Methods and Outcomes

Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease

Open access
Lindahl, J. P., Hartmann, A., Horneland, R., Holdaas, H., Reisæter, A. V., Midtvedt, K., Leivestad, T., Øyen, O. +1 more·2013·Diabetologia

Abstract

Aims/hypothesis We aimed to determine whether simultaneous pancreas and kidney (SPK) transplantation would improve patient and kidney graft survival in diabetic end-stage renal disease (ESRD) compared with kidney transplantation alone (KTA).Methods Follow-up data were retrieved for all 630 patients with diabetic ESRD who had received SPK or KTA at our centre from 1983 to the end of 2010. Recipients younger than 55 years of age received either an SPK (n = 222) or, if available, a single live donor kidney (LDK; n = 171). Older recipients and recipients with greater comorbidity received a single deceased donor kidney (DDK; n = 237). Survival was analysed by the Kaplan-Meier method and in multivariate Cox regression analysis adjusting for recipient and donor characteristics.Results Patient survival was superior in SPK compared with both LDK and DDK recipients in univariate analysis. Follow-up time (mean ± SD) after transplantation was 7.1 ± 5.7 years. Median actuarial patient survival was 14.0 years for SPK, 11.5 years for LDK and 6.7 years for DDK recipients. In multivariate analyses including recipient age, sex, treatment modality, time on dialysis and era, SPK transplantation was protective for all-cause mortality compared with both LDK (p = 0.02) and DDK (p = 0.029) transplantation. After the year 2000, overall patient survival improved compared with previous years (HR 0.40, 95% CI 0.30, 0.55; p < 0.001). Pancreas graft survival also improved after 2000, with a 5 year graft survival rate of 78% vs 61% in previous years (1988-1999).Conclusions/interpretation Recipients of SPK transplants have superior patient survival compared with both LDK and DDK recipients, with improved results seen over the last decade.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-013-2888-y

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pancreas transplantation has been done for more than 50 years and is standard care for patients with end-stage renal failure who need a kidney transplant.

    “Pancreas transplants have been performed for over 50 years and have become a standard-of-care treatment in individuals who have developed end-stage renal failure and require kidney transplantation.158”

    From Type 1 diabetes (2018) · cites this paper as [158]

    The Introduction dates the first pancreas transplant to 1966, consistent with a history of more than 50 years by the time of the citing statement. It calls transplantation an effective option especially for patients with diabetes and end-stage renal disease, but does not establish it as standard care for everyone with end-stage renal failure who needs a kidney transplant; it describes eligibility limits and kidney-only alternatives. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lindahl, J. P., Hartmann, A., Horneland, R., Holdaas, H., Reisæter, A. V., Midtvedt, K., Leivestad, T., Øyen, O., & Jenssen, T.
Affiliations
Oslo University Hospital (NO)
Corresponding author
Lindahl, J. P.
Venue
Diabetologia
Published
2013-04-03
Volume
56
Issue
6
Pages
1364-1371
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2067386593
Cited by
61
References
37
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 5 · 2014: 5 · 2013: 1
FWCI
4.13
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
simultaneous pancreas-kidney transplantation, diabetic end-stage renal disease, kidney transplantation, patient survival, renal allograft survival, living donor kidney, deceased donor kidney, all-cause mortality, diabetes mellitus
MeSH terms
Adult, Female, Graft Survival, Humans, Immunosuppressive Agents, Kidney Failure, Chronic, Male, Middle Aged, Regression Analysis, Retrospective Studies, Risk Factors, Time Factors, Multivariate Analysis, Proportional Hazards Models, Kidney Transplantation, Pancreas Transplantation, Treatment Outcome, Living Donors, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review